Literature DB >> 18222020

SOCS1 downregulation in dendritic cells promotes memory T-cell responses.

Melissa Aldrich1, Denise Sanders, Natasha Lapteva, Xue F Huang, Si-Yi Chen.   

Abstract

SOCS1-1 is crucial for control of immune cell cytokine expression, including those cytokines known to enable memory T-cell formation and homeostasis. In this study, we found that immunization with SOCS1-downregulated bone marrow-derived dendritic cells generated increased antigen-specific CD8(+) T memory cells and antigen-specific responses, as measured by ELISPOT, CTL assays, serum ELISAs, and T-cell proliferation assays. Bone marrow-derived dendritic cells in which SOCS1 was downregulated expressed increased levels of surface IL-15Ra and thymic leukemia (TL) antigen, both of which support memory cell development. This work supports a crucial role for SOCS1 in regulation of dendritic cell-directed generation of memory T-cell responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18222020      PMCID: PMC2750824          DOI: 10.1016/j.vaccine.2007.11.020

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  41 in total

Review 1.  Not all CD4+ memory T cells are long lived.

Authors:  Jennifer M Robertson; Megan MacLeod; Vanessa S Marsden; John W Kappler; Philippa Marrack
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

2.  Cutting edge: IL-7-independent regulation of IL-7 receptor alpha expression and memory CD8 T cell development.

Authors:  Kimberly D Klonowski; Kristina J Williams; Amanda L Marzo; Leo Lefrançois
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

3.  IL-12-programmed long-term CD8+ T cell responses require STAT4.

Authors:  Qingsheng Li; Cheryl Eppolito; Kunle Odunsi; Protul A Shrikant
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

4.  The IL-15/IL-15Ralpha on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells.

Authors:  Noriko Sato; Hiral J Patel; Thomas A Waldmann; Yutaka Tagaya
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-03       Impact factor: 11.205

Review 5.  Developing and maintaining protective CD8+ memory T cells.

Authors:  Matthew A Williams; Brittany J Holmes; Joseph C Sun; Michael J Bevan
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

6.  Regulation of IL-21 signaling by suppressor of cytokine signaling-1 (SOCS1) in CD8(+) T lymphocytes.

Authors:  Julien Gagnon; Sheela Ramanathan; Chantal Leblanc; Subburaj Ilangumaran
Journal:  Cell Signal       Date:  2006-11-28       Impact factor: 4.315

Review 7.  The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design.

Authors:  Thomas A Waldmann
Journal:  Nat Rev Immunol       Date:  2006-08       Impact factor: 53.106

8.  Suppressor of cytokine signaling-1 is an IL-4-inducible gene in macrophages and feedback inhibits IL-4 signaling.

Authors:  H Dickensheets; N Vazquez; F Sheikh; S Gingras; P J Murray; J J Ryan; R P Donnelly
Journal:  Genes Immun       Date:  2006-11-09       Impact factor: 2.676

9.  Augmented IL-7 signaling during viral infection drives greater expansion of effector T cells but does not enhance memory.

Authors:  Joseph C Sun; Sophie M Lehar; Michael J Bevan
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

10.  Do CD8 effector cells need IL-7R expression to become resting memory cells?

Authors:  Eva Buentke; Anne Mathiot; Mauro Tolaini; James Di Santo; Rose Zamoyska; Benedict Seddon
Journal:  Blood       Date:  2006-05-16       Impact factor: 22.113

View more
  3 in total

1.  Modulation of Decidual Macrophage Polarization by Macrophage Colony-Stimulating Factor Derived from First-Trimester Decidual Cells: Implication in Preeclampsia.

Authors:  Min Li; Longzhu Piao; Chie-Pein Chen; Xianqing Wu; Chang-Ching Yeh; Rachel Masch; Chi-Chang Chang; S Joseph Huang
Journal:  Am J Pathol       Date:  2016-03-10       Impact factor: 4.307

2.  Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC.

Authors:  Chunlei Ge; Ruilei Li; Haifeng Song; Tao Geng; Jinyan Yang; Qinghua Tan; Linfeng Song; Ying Wang; Yuanbo Xue; Zhen Li; Suwei Dong; Zhiwei Zhang; Na Zhang; Jiyin Guo; Lin Hua; Siyi Chen; Xin Song
Journal:  BMC Cancer       Date:  2017-12-21       Impact factor: 4.430

Review 3.  Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives.

Authors:  Jing-Bo Wang; Xue Huang; Fu-Rong Li
Journal:  Cancer Commun (Lond)       Date:  2019-07-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.